medline.ch Onkologie Urologische Tumoren

	Comparative Analysis of ISM-1 and B7-H3 Expression in Castration-Resistant Prostate Adenocarcinoma: Associations with Tumor Aggressiveness and Resistance Dynamics. Medicina (Kaunas) Kaya , Öztürk A, Yüceer RO, Öztürk NB. PMID: 41901559 [PubMed - indexed for MEDLINE]
	Improved Anticancer Properties of Silver Nanoparticles by Albumin Coating in Prostate Cancer Cell Lines: An In Vitro Study. Pharmaceutics Zareian Baghdadabad L, Menbari Oskouie I, Yahyazadeh SR, Golmohammadi P, Mashhadi R, Khoshchehreh M, Aghamir SMK. PMID: 41900824 [PubMed]
	The Role of Gut Microbiome in Prostate Cancer: Current Evidence and Emerging Opportunities. Cancers (Basel) Huang J, Zhu XH, Trotman LC, Tsao CK. PMID: 41899599 [PubMed]
	Efficacy and Toxicity in Scheduled Intravesical Gemcitabine Versus Bacillus Calmette-GuÃ©rin for Bladder Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel) Kim DK, Jeon J, Kwon JK, Bang S, Lee KS, Koo KC, Cho KS. PMID: 41899592 [PubMed]
	Bladder Preservation with Concurrent Chemoradiotherapy Following Complete Response to Induction Systemic Therapy in Patients with Muscle-Invasive Bladder Cancer: A Review of the Existing Literature. Cancers (Basel) Ntoumas GN, Kougioumtzopoulou A, Desse D, Fragkoulis C, Papadopoulos G, Kostouros E, Michaletou D, Kouloulias V, Zygogianni A, Georgakopoulos I. PMID: 41899563 [PubMed]
	Nerve-Sparing in High-Risk Prostate Cancer: Advantages and Pitfalls of Current Strategies and Technologies. Cancers (Basel) Robesti D, Russo P, Fallara G, Blank F, Valerio M, Tewari AK, Montorsi F, Ploussard G, Patil N, Martini A. PMID: 41899547 [PubMed]
	Spatial Immune Profiling and AI-Based Classifiers Identify Predictors of BCG Therapy Outcomes in High-Risk Non-Muscle-Invasive Bladder Cancer. Cancers (Basel) Lillesand M, Austdal M, Mroz J, Skaland I, Gudlaugsson E, Jong FC, Zuiverloon TCM, Engan K, Janssen EAM. PMID: 41899544 [PubMed]
	Quality and Usability of Prostate Cancer Information Generated by Artificial Intelligence Chatbots: A Comparative Analysis. Cancers (Basel) Al-Khanaty A, Santucci J, Hennes D, Sathianathen N, Delgado C, Sharma K, Dinneen E, Sandhu K, Chen D, Eapen R, Moon D, Jack G, Goad J, Siva S, Ali M, Bolton D, Lawrentschuk N, Murphy DG, Perera M. PMID: 41899512 [PubMed]
	Hypoxia-Driven Mechanisms of Drug Resistance in Prostate Cancer. Cancers (Basel) Ressel MR, Flores CE, Warfel NA. PMID: 41899504 [PubMed]
	Novel Immunotherapeutic Strategies for Castration-Resistant Prostate Cancer: Mechanisms and Clinical Advances. Curr Issues Mol Biol Xia X, Xia Z, Yu L. PMID: 41899434 [PubMed]
	Oncofertility in Women with Renal Cell Carcinoma in the Immune Checkpoint Inhibitors Era: A Multidisciplinary Perspective. J Clin Med Miscia M, Raffone A, Mollica V, Piazza P, Cipriani L, Maletta M, Ferla S, Perucci M, Cortese F, Pesaresi I, Pazzaglia E, Cobellis L, Seracchioli R, Raimondo D. PMID: 41899374 [PubMed]
	Clear Cell Renal Cell Carcinoma with Synchronous Bladder Metastasis: Diagnostic, Surgical, and Pathological Insights from a Rare Presentation. J Clin Med Benkova-Petrova M, Petrov A, Abushev P, Kirilov P, Marinov S, Malinova D, Stoeva-Grigorova S. PMID: 41899022 [PubMed]
	Inflammatory and Nested Testicular Sex Cord Tumors: Clinical and Molecular Characterization. Genes (Basel) Vlachostergios PJ, Karasavvidou F, Evmorfopoulos K, Zachos I, Tzortzis V. PMID: 41898873 [PubMed - indexed for MEDLINE]
	Intermittent Fasting and Androgen Receptor Signaling in Prostate Cancer: Metabolic Crosstalk and Therapeutic Implications. Int J Mol Sci Gromadzka G, Bendykowska M. PMID: 41898513 [PubMed - indexed for MEDLINE]
	Can Tc-99m-PSMA SPECT/CT Be Used as Accessible Alternative for Diagnosis of Biochemically Recurrent Prostate Cancer? A Prospective Study. Diagnostics (Basel) Milo, Slobodanka B, Tomislav P, Zoran B, Strahinja O, Isidora GM, Milica S, Jelena P, Ana I, , Vera A. PMID: 41897628 [PubMed]
	Changes in PSA-Based Early Detection of Prostate Cancer over a 12-Year Period: Findings from the German KABOT Study. Healthcare (Basel) Braun KP, Vogel T, May M, Gilfrich C, Herrmann M, Kravchuk AP, Maurer J, Wolff I. PMID: 41897201 [PubMed]
	CT-based renal artery caliber change as a potential imaging marker of treatment response in renal cell carcinoma; an exploratory imaging study. Cancer Imaging Asanuma H, Okamoto T, Yoshizawa T, Oishi T, Hamaya T, Kodama H, Narita T, Mikami J, Fujita N, Yoneyama T, Yamamoto H, Imai A, Ohyama C, Hatakeyama S. PMID: 41897001 [PubMed - as supplied by publisher]
	Added value of systematic biopsy in patients with positive MRI-US fusion targeted biopsy for clinically significant prostate cancer: a single-center retrospective study. BMC Urol Zhang J, Chen J, Jin J, Chen J, Zheng B. PMID: 41896841 [PubMed - as supplied by publisher]
	Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trial. BJU Int Sushentsev N, Warren AY, Colling R, Verrill C, Pazukhina E, Blyuss O, Zaikin A, Seibert TM, Barrett T, Oxley J, Mills IG, Bryant RJ, Lane JA, Donovan JL, Neal DE, Hamdy FC. PMID: 41896701 [PubMed - as supplied by publisher]
	Clinicopathological Characteristics and Clinical Course of Non-muscle-invasive Bladder Cancer Secondary to Radical Nephroureterectomy. Anticancer Res Sato T, Sano T, Adachi H, Ikeda Y, Takemoto J, Myoen S, Mitsuzuka K, Kyan A, Aoki H, Tokuyama S, Saito H, Yamashita S, Arai Y, Kobayashi T, Ito A. PMID: 41895764 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 177111

Seite 1 von 8856

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung